In the universities of God’s uprising, the action of the drug is based on the deactivation of a protein associated with a gene that suppresses tooth growth. Detection of laboratory tests was performed and found no very common effects. Commercial preparation is expected before 2030.
The named clinics are used for three days, this is 30-64 years old, at least one molar was not found. The medicine will be administered intravenously. Previously, using a tax method, it was already possible to restore teeth in ferrets and mice.
By the end of the 11-month period, patients will have a delay of 2 or 7 hours and no more than 4 teeth or more of expected dental deficiency. Next, experiments will be conducted on people suffering from edentia and permanent tooth loss due to exposure to environmental factors.
The project’s lead researcher, Katsu Takahashi, a recognized expert in the fields of dentistry and molecular biology, has been working on tooth regeneration techniques since 2005 and represents the widest possible application. S + m are preparing for ongoing clinical trials now, in the past about age.
Source: Tech Cult
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
